Maternal and Fetal Characteristics Influencing Image Quality in Prenatal Ultrasonography

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

198 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-01

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this observational study is to identify maternal and fetal characteristics that impact image quality in prenatal ultrasonography. The investigators have assembled a retrospective cohort of 198 patients, each contributing three ultrasound images taken between 18 and 18 weeks and 6 days of gestation. For each image, the investigators assess the quality of two distinct elements as well as the overall image through both subjective and objective evaluations.

The primary questions the study seeks to address are:

What maternal and fetal characteristics influence image quality in prenatal ultrasonography?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype

NCT03239002

Abnormality of the Neck Fetus; Abnormal, Affecting Management of Pregnancy

COMPLETED

The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy

NCT06806644

Nephropathy

COMPLETED

Follow up of Increased Nuchal Translucency :Study of 2010 to 2018 of Limoges Hospital

NCT04028453

Ultrasound Fetal Medicine

COMPLETED

Pregnancies Complicated by Fetal Anomalies

NCT02505464

Pregnancy Congenital Abnormalities

RECRUITING

Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications

NCT01404221

Pregnancy Fetal Aneuploidy

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultrasonography Obstetrics Fetus Pregnant Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patient who underwent ultrasound between 18 weeks and 18 weeks + 6 days for prenatal diagnosis

* Ultrasound performed by the same practitioner
* Ultrasound performed on the same ultrasound machine "Voluson E10", with the "RM6C" probe

Exclusion Criteria

\- Patient's refusal

* Use of another ultrasound device other than the "Voluson E10", and/or an ultrasound probe other than the "RM6C"
* Intrauterine fetal deaths

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No